Correlation Between Pfizer and Listed Funds

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Listed Funds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Listed Funds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Listed Funds Trust, you can compare the effects of market volatilities on Pfizer and Listed Funds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Listed Funds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Listed Funds.

Diversification Opportunities for Pfizer and Listed Funds

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Listed is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Listed Funds Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Listed Funds Trust and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Listed Funds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Listed Funds Trust has no effect on the direction of Pfizer i.e., Pfizer and Listed Funds go up and down completely randomly.

Pair Corralation between Pfizer and Listed Funds

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Listed Funds. In addition to that, Pfizer is 1.22 times more volatile than Listed Funds Trust. It trades about -0.04 of its total potential returns per unit of risk. Listed Funds Trust is currently generating about 0.12 per unit of volatility. If you would invest  2,808  in Listed Funds Trust on September 1, 2024 and sell it today you would earn a total of  479.00  from holding Listed Funds Trust or generate 17.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

Pfizer Inc  vs.  Listed Funds Trust

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Listed Funds Trust 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Listed Funds Trust are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting forward indicators, Listed Funds reported solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Listed Funds Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Listed Funds

The main advantage of trading using opposite Pfizer and Listed Funds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Listed Funds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Listed Funds will offset losses from the drop in Listed Funds' long position.
The idea behind Pfizer Inc and Listed Funds Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios